Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 190
Endocrine and Metabolic Disorders Drugs 166
Gastrointestinal Drugs 148
Immune Disorders Drugs 129
Central Nervous System Drugs 128
Biopharmaceuticals 88
Pharmaceuticals 84
Hematological Drugs 79
Vaccines 77
Clinical Trials 67
Drug Discovery 63
Cardiovascular Drugs 60
Diabetes Drugs 56
Infectious Diseases Drugs 53
Leukemia Drugs 53
Mental Disorders Drugs 46
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 41
Liver and Kidney Disorders Drugs 32
Infusions and Injectables 31
Over the Counter (OTC) Drugs 30
Lung Cancer Drugs 24
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Respiratory Drugs 18
Pharmaceutical Manufacturing 17
Antibiotics 16
Analgesics 15
Drugs by Therapeutic Area 13
Immunosuppressive Drugs 13
Pharmaceutical Intermediates 12
Schizophrenia Drugs 12
Prostate Cancer Drugs 11
Skin Cancer Drugs 11
Optical Disorders Drugs 10
Anti-Obesity Drugs 9
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Transdermal and Transmucosal Drug Delivery 6
Thyroid Cancer Drugs 6
Uterine Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Brain Cancer Drugs 4
Cough and Cold Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



285 reviews

1,651 Results (Page 20 of 83)
- Relevance
  Sort by

Aids Related Cancer Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
80 Pages
Global

From

€3500EUR$4,213USD£3,110GBP

Immunoglobulins: Global Market Outlook

 Report
March 2023
64 Pages
Global

From

€2225EUR$2,500USD£1,910GBP

Kallikrein Inhibitors Market - Global Forecast 2026-2032

 Report
January 2026
180 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Integrin Inhibitors Market - Global Forecast 2026-2032

 Report
January 2026
198 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

HAE Treatments Market - Global Forecast 2026-2032

 Report
January 2026
194 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Human Rabies Immunoglobulin Market - Global Forecast 2026-2032

 Report
January 2026
186 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Hyperimmune Globulin Product Market - Global Forecast 2026-2032

 Report
January 2026
189 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Plasma Therapy Market - Global Forecast 2026-2032

 Report
January 2026
194 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Nucleic Acid-Based Drugs Market - Global Forecast 2026-2032

 Report
January 2026
183 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Fabry Disease Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
August 2026
106 Pages
Global

From

€4227EUR$4,750USD£3,628GBP

Metabolic Syndrome Market (2023 Edition): Analysis By Indication (NASH, IRS, Hypercholesterolemia, Obesity Syndrome, Others), By Molecule Type, Route of Administration, By Region, By Country: Market Insights and Forecast (2018-2028)

 Report
June 2023
270 Pages
Global

From

€2136EUR$2,400USD£1,833GBP

Lansoprazole Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
74 Pages
Global

From

€3500EUR$4,213USD£3,110GBP

Crohn's Disease Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
183 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Anti-Rheumatics Market - Global Forecast 2026-2032

 Report
January 2026
194 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Subcutaneous Immunoglobulin Market - Global Forecast 2026-2032

 Report
January 2026
188 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Bradykinin Receptor Antagonists Market - Global Forecast 2026-2032

 Report
January 2026
188 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Small Molecule Drug Conjugates Market - Global Forecast 2026-2032

 Report
January 2026
197 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Immunoglobulins Market - Global Outlook & Forecast 2021-2026

 Report
September 2021
262 Pages
Global

From

€2836EUR$3,188USD£2,435GBP

€3337EUR$3,750USD£2,865GBP

Gaucher Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
September 2023
119 Pages
Global

From

€2225EUR$2,500USD£1,910GBP

Febuxostat Market - Global Forecast 2026-2032

 Report
January 2026
191 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

1,651 Results (Page 20 of 83)
- 1
- 18
- 19
- 20
- 21
- 22

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.